These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 34970597)
1. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset. Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597 [No Abstract] [Full Text] [Related]
2. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset. Jang BS; Kim IA Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282 [TBL] [Abstract][Full Text] [Related]
3. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study. Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709 [TBL] [Abstract][Full Text] [Related]
4. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA. Jang BS; Kim IA Radiother Oncol; 2018 Aug; 128(2):245-253. PubMed ID: 29784449 [TBL] [Abstract][Full Text] [Related]
5. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma. Li Z; Shen L; Li Y; Shen L; Li N Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984 [TBL] [Abstract][Full Text] [Related]
6. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related]
7. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma. Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma. Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797 [TBL] [Abstract][Full Text] [Related]
9. PD-1 and PD-L1 Expression Predicts Radiosensitivity and Clinical Outcomes in Head and Neck Cancer and is Associated with HPV Infection. Lyu X; Zhang M; Li G; Jiang Y; Qiao Q J Cancer; 2019; 10(4):937-948. PubMed ID: 30854100 [No Abstract] [Full Text] [Related]
10. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma. Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463 [TBL] [Abstract][Full Text] [Related]
11. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma. Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907 [No Abstract] [Full Text] [Related]
12. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma. Yang F; Zhou LQ; Yang HW; Wang YJ Front Genet; 2022; 13():927614. PubMed ID: 36092911 [No Abstract] [Full Text] [Related]
13. MTDH enhances radiosensitivity of head and neck squamous cell carcinoma by promoting ferroptosis based on a prognostic signature. Cao X; Ge Y; Yan Z; Hu X; Peng F; Zhang Y; He X; Zong D J Radiat Res; 2024 Jan; 65(1):10-27. PubMed ID: 37981296 [TBL] [Abstract][Full Text] [Related]
14. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma. Liu J; Lu J; Li W BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159 [TBL] [Abstract][Full Text] [Related]
15. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma. Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937 [TBL] [Abstract][Full Text] [Related]
16. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
17. A Signature of N Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X Front Immunol; 2022; 13():809872. PubMed ID: 35185897 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma. Liu S; Liu W; Ding Z; Yang X; Jiang Y; Wu Y; Liu Y; Wu J Front Mol Biosci; 2022; 9():912620. PubMed ID: 36339718 [No Abstract] [Full Text] [Related]
19. A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancer. Zhang P; Yang J; Zhong X; Selistre-de-Araujo HS; Boussios S; Ma Y; Fang H Transl Cancer Res; 2024 Mar; 13(3):1554-1566. PubMed ID: 38617520 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma. Lu C; Sun Q; Guo Y; Han X; Zhang M; Liu J; Wang Y; Mou Y; Li Y; Song X Clin Transl Radiat Oncol; 2023 Nov; 43():100686. PubMed ID: 37854672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]